1. Home
  2. NLY vs NBIX Comparison

NLY vs NBIX Comparison

Compare NLY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annaly Capital Management Inc.

NLY

Annaly Capital Management Inc.

HOLD

Current Price

$21.87

Market Cap

16.3B

Sector

Real Estate

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$158.82

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NLY
NBIX
Founded
1996
1992
Country
United States
United States
Employees
212
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
13.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NLY
NBIX
Price
$21.87
$158.82
Analyst Decision
Buy
Strong Buy
Analyst Count
11
22
Target Price
$23.82
$180.91
AVG Volume (30 Days)
5.1M
1.1M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
12.42%
N/A
EPS Growth
N/A
41.95
EPS
N/A
1.91
Revenue
N/A
$161,626,000.00
Revenue This Year
$188.83
$24.73
Revenue Next Year
$2.40
$13.14
P/E Ratio
$7.88
$81.92
Revenue Growth
N/A
977.51
52 Week Low
$18.58
$121.83
52 Week High
$24.52
$162.39

Technical Indicators

Market Signals
Indicator
NLY
NBIX
Relative Strength Index (RSI) 47.86 70.80
Support Level $21.38 $133.96
Resistance Level $22.29 $160.08
Average True Range (ATR) 0.32 4.01
MACD -0.02 -0.31
Stochastic Oscillator 46.74 69.93

Price Performance

Historical Comparison
NLY
NBIX

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are: the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: